Andere Sprachen Vanda Pharmaceuticals Inc.

Aktien

A0JJT3

US9216591084

VNDA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
4,88 ^USD	+4,27 %		+5,63 %	+15,64 %

25.04.	Shareholder Capital fordert den Vorstand von Vanda Pharma auf, das Angebot von Future Pak zu überdenken	RE
22.04.	Oberster Gerichtshof der USA lehnt Klage von Vanda Pharmaceuticals gegen Patente für Schlafmittel ab	RE

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024	30.04.
Vanda Strikes Out At The Supreme Court	30.04.
Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer	25.04.
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals	25.04.
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ ANDA Litigation	23.04.
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation	23.04.
Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court	22.04.
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents	22.04.
Butler Hall Capital urges Vanda to engage in sales discussions	19.04.
Deals of the day-Mergers and acquisitions	17.04.
Sector Update: Health Care Stocks Retreating Late Afternoon	17.04.
Sector Update: Health Care Stocks Mixed Wednesday Afternoon	17.04.
Sector Update: Health Care	17.04.
Top Midday Gainers	17.04.
Vanda Pharmaceuticals Adopts Stockholder Rights Plan; Shares Rise	17.04.
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan	17.04.
Vanda Pharmaceuticals' Board Rejects all Unsolicited Takeover Proposals From Future Pak	17.04.
Vanda Pharmaceuticals rejects takeover proposal from Future Pak	17.04.
Traders Digest Earnings After Rate-Driven Losses, US Equity Futures Rebound Slightly	17.04.
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak	17.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Vanda Pharmaceuticals Inc.

Aktien

A0JJT3

US9216591084

VNDA

Andere Sprachen

Filter